| Joyce Ting, | |
|
757 Westwood Plz, Los Angeles, CA 90095-8358 | |
| (310) 267-7821 | |
| Not Available |
| Full Name | Joyce Ting |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 757 Westwood Plz, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114675410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 65214 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joyce Ting, 757 Westwood Plz, Los Angeles, CA 90095-8358 Ph: (310) 267-7821 | Joyce Ting, 757 Westwood Plz, Los Angeles, CA 90095-8358 Ph: (310) 267-7821 |
News Archive
Cangene Corporation announces today that a normal course issuer bid has been accepted by The Toronto Stock Exchange.
Despite a veto threat from the White House, the House on Wednesday voted 349-62 to approve legislation (HR 5613) that would place a one-year moratorium on seven new Medicaid regulations, the AP/Houston Chronicle reports (Abrams, AP/Houston Chronicle, 4/24).
The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.
They're a double-edged sword for nursing home residents and staff – making it easier and safer to handle a basic bodily function, but putting frail patients in danger of infections that can lead to confusion, falls and death.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.
› Verified 4 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |